🇺🇸 FDA
Pipeline program

Epinephrine (0.125 mg/inhalation)

API-E004-CL-I

Approved other completed

Quick answer

Epinephrine (0.125 mg/inhalation) for Pharmacokinetics is a Approved program (other) at Amphastar Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Amphastar Pharmaceuticals
Indication
Pharmacokinetics
Phase
Approved
Modality
other
Status
completed

Clinical trials